Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Interparfums (IPAR) Cash & Equivalents: 2010-2025

Historic Cash & Equivalents for Interparfums (IPAR) over the last 16 years, with Sep 2025 value amounting to $110.4 million.

  • Interparfums' Cash & Equivalents rose 40.78% to $110.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $110.4 million, marking a year-over-year increase of 40.78%. This contributed to the annual value of $125.4 million for FY2024, which is 41.79% up from last year.
  • According to the latest figures from Q3 2025, Interparfums' Cash & Equivalents is $110.4 million, which was down 27.11% from $151.5 million recorded in Q2 2025.
  • In the past 5 years, Interparfums' Cash & Equivalents ranged from a high of $159.6 billion in Q4 2021 and a low of $21.0 million during Q1 2024.
  • Moreover, its 3-year median value for Cash & Equivalents was $88.5 million (2023), whereas its average is $92.2 million.
  • In the last 5 years, Interparfums' Cash & Equivalents skyrocketed by 93,966.51% in 2021 and then crashed by 99.93% in 2022.
  • Quarterly analysis of 5 years shows Interparfums' Cash & Equivalents stood at $159.6 billion in 2021, then slumped by 99.93% to $104.7 million in 2022, then fell by 15.52% to $88.5 million in 2023, then skyrocketed by 41.79% to $125.4 million in 2024, then surged by 40.78% to $110.4 million in 2025.
  • Its Cash & Equivalents stands at $110.4 million for Q3 2025, versus $151.5 million for Q2 2025 and $96.6 million for Q1 2025.